Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins.

Liou YC, Zhou XZ, Lu KP.

Trends Biochem Sci. 2011 Oct;36(10):501-14. doi: 10.1016/j.tibs.2011.07.001. Epub 2011 Aug 17. Review.

2.

Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.

Zhou XZ, Lu PJ, Wulf G, Lu KP.

Cell Mol Life Sci. 1999 Nov 30;56(9-10):788-806. Review.

PMID:
11212339
3.

[Recent advances in the study of pin1 and its inhibitors].

Zhang CJ, Zhang ZH, Xu BL, Wang YL.

Yao Xue Xue Bao. 2008 Jan;43(1):9-17. Review. Chinese.

PMID:
18357725
4.

Regulation of mitochondrial apoptosis by Pin1 in cancer and neurodegeneration.

Sorrentino G, Comel A, Mantovani F, Del Sal G.

Mitochondrion. 2014 Nov;19 Pt A:88-96. doi: 10.1016/j.mito.2014.08.003. Epub 2014 Aug 15. Review.

PMID:
25132079
5.

Prolyl isomerase Pin1 in cancer.

Lu Z, Hunter T.

Cell Res. 2014 Sep;24(9):1033-49. doi: 10.1038/cr.2014.109. Epub 2014 Aug 15. Review.

6.

Pin1 and nuclear receptors: a new language?

La Montagna R, Caligiuri I, Giordano A, Rizzolio F.

J Cell Physiol. 2013 Sep;228(9):1799-801. doi: 10.1002/jcp.24316. Review.

PMID:
23280577
7.
8.

Pinning down proline-directed phosphorylation signaling.

Lu KP, Liou YC, Zhou XZ.

Trends Cell Biol. 2002 Apr;12(4):164-72. Review.

PMID:
11978535
9.

The prolyl isomerase Pin1 in breast development and cancer.

Wulf G, Ryo A, Liou YC, Lu KP.

Breast Cancer Res. 2003;5(2):76-82. Epub 2003 Jan 28. Review.

10.

Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease.

Lee TH, Pastorino L, Lu KP.

Expert Rev Mol Med. 2011 Jun 20;13:e21. doi: 10.1017/S1462399411001906. Review.

PMID:
21682951
11.

Exploring the molecular function of PIN1 by nuclear magnetic resonance.

Landrieu I, Smet C, Wieruszeski JM, Sambo AV, Wintjens R, Buée L, Lippens G.

Curr Protein Pept Sci. 2006 Jun;7(3):179-94. Review.

PMID:
16787258
12.

Peptidyl-Prolyl cis/trans Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma.

Kim G, Kim JY, Choi HS.

Biol Pharm Bull. 2015;38(7):975-9. doi: 10.1248/bpb.b15-00245. Review.

13.

The peptidyl-prolyl isomerase Pin1.

Joseph JD, Yeh ES, Swenson KI, Means AR, Winkler.

Prog Cell Cycle Res. 2003;5:477-87. Review.

PMID:
14593743
14.

Phosphorylation-specific prolyl isomerization: is there an underlying theme?

Wulf G, Finn G, Suizu F, Lu KP.

Nat Cell Biol. 2005 May;7(5):435-41. Review.

PMID:
15867923
15.

Pin1: Intimate involvement with the regulatory protein kinase networks in the global phosphorylation landscape.

Litchfield DW, Shilton BH, Brandl CJ, Gyenis L.

Biochim Biophys Acta. 2015 Oct;1850(10):2077-86. doi: 10.1016/j.bbagen.2015.02.018. Epub 2015 Mar 10. Review.

PMID:
25766872
16.

[Prolyl isomerase pin1 protecting against aging diseases].

Uchida T, Fanghaenel J, Uchida C, Ostroff L.

Tanpakushitsu Kakusan Koso. 2005 Sep;50(11):1413-9. Review. Japanese. No abstract available.

PMID:
16146189
17.

[Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].

Marsolier J, Weitzman JB.

Med Sci (Paris). 2014 Aug-Sep;30(8-9):772-8. doi: 10.1051/medsci/20143008015. Epub 2014 Sep 1. Review. French.

18.

Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.

Rostam MA, Piva TJ, Rezaei HB, Kamato D, Little PJ, Zheng W, Osman N.

Clin Exp Pharmacol Physiol. 2015 Feb;42(2):117-24. doi: 10.1111/1440-1681.12335. Review.

PMID:
25377120
19.

Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products.

Takahashi K, Shimizu T, Kosaka K, Hidaka M, Uchida C, Uchida T.

Curr Drug Targets. 2014;15(10):973-81. Review.

PMID:
25182609
20.

Pin1: a molecular orchestrator in the heart.

Hariharan N, Sussman MA.

Trends Cardiovasc Med. 2014 Aug;24(6):256-62. doi: 10.1016/j.tcm.2014.05.010. Epub 2014 Jun 4. Review.

Supplemental Content

Support Center